Skip to main content
SpringerLink
Log in

Use of ARBs and ACE inhibitors in pregnancy: Japan issues alert

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pharmaceuticals and Medical Devices Agency of Japan. Adverse Events in Pregnant Women and Foetuses Associated with Use of Angiotensin II Receptor Blockers and Angiotensin Converting Enzyme Inhibitors. Pharmaceuticals and Medical Devices Safety Information : 10-17, No. 316, Sep 2014. Available from: URL: http://www.pmda.go.jp/english/service/pdf/precautions/PMDSI-316.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Use of ARBs and ACE inhibitors in pregnancy: Japan issues alert. Reactions Weekly 1527, 8 (2014). https://doi.org/10.1007/s40278-014-4802-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-4802-x

Search

Navigation